Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Phospholipase A2 enzymes play key roles in skin health and disease.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Herbal remedies might help with hair loss but need more research for safety and effectiveness.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Scientists discovered a new way UVB light increases skin pigmentation through the ATP-P2X7 pathway.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Myotonic Dystrophy may age cells faster, and drugs that target aging could be potential treatments.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Mesenchymal stem cells show promise for effective skin repair and regeneration.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Animal models have helped understand hair loss from alopecia areata and find new treatments.